The pharmaceuticals company reported a net loss of Rs 68.13 crore in the March 2021 quarter. However, the loss has narrowed 60 per cent. The company reported a net loss of Rs 159.15 in the same quarter previous year. The counter shed 7 per cent to Rs 65.45 on Friday, but was trading at Rs 66.20 at 10.45 am. BSE Sensex was trading with mild cuts at 52,676.05 at the same time. The counter had settled at Rs 70.35 on Thursday.
